Benign vascular neoplasmof proliferating endothelial cells; most common soft tissue tumor of infancy
Not vascular malformation
2018 revised classification by International Society for Study of Vascular Anomalies (ISSVA) retains 2 main categories
Vascular tumors: True neoplasms with cellular proliferation; generally grow out of proportion to patient
Vascular malformation: Congenital errors of vessel development; generally grow commensurate with patient
IMAGING
General Features
Imaging Recommendations
DIFFERENTIAL DIAGNOSIS
PATHOLOGY
General Features
Microscopic Features
Immunohistochemical Features
CLINICAL ISSUES
Presentation
Demographics
Natural History & Prognosis
Treatment
DIAGNOSTIC CHECKLIST
Consider
Selected References
ISSVA 2018 Classification
Laken PA: Infantile hemangiomas: pathogenesis and review of propranolol use. Adv Neonatal Care. 16(2):135-42, 2016
Merrow AC et al: 2014 Revised classification of vascular lesions from the International Society for the Study of Vascular Anomalies: radiologic-pathologic update. Radiographics. 36(5):1494-516, 2016
Wassef M et al: Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics. 136(1):e203-14, 2015
Blei F et al: Current workup and therapy of infantile hemangiomas. Clin Dermatol. 32(4):459-70, 2014
Nasseri E et al: Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol. 70(1):75-9, 2014
Bingham MM et al: Propranolol reduces infantile hemangioma volume and vessel density. Otolaryngol Head Neck Surg. 147(2):338-44, 2012
Restrepo R et al: Hemangiomas revisited: the useful, the unusual and the new. Part 1: overview and clinical and imaging characteristics. Pediatr Radiol. 41(7):895-904, 2011
Restrepo R et al: Hemangiomas revisited: the useful, the unusual and the new. Part 2: endangering hemangiomas and treatment. Pediatr Radiol. 41(7):905-15, 2011
Holmes WJ et al: Propranolol as first-line treatment for infantile hemangiomas. Plast Reconstr Surg. 125(1):420-1, 2010
Maturo S et al: Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol. 74(3):323-5, 2010
Sinno H et al: Management of infantile parotid gland hemangiomas: a 40-year experience. Plast Reconstr Surg. 125(1):265-73, 2010
Storch CH et al: Propranolol for infantile haemangiomas - insights into the molecular mechanisms of action. Br J Dermatol. 163(2):269-74, 2010
Metry D et al: Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics. 124(5):1447-56, 2009
Judd CD et al: Intracranial infantile hemangiomas associated with PHACE syndrome. AJNR Am J Neuroradiol. 28(1):25-9, 2007
Drolet BA et al: Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics. 117(3):959-64, 2006
Rossi A et al: Agenesis of bilateral internal carotid arteries in the PHACE syndrome. AJNR Am J Neuroradiol. 27(8):1602, 2006
Kronenberg A et al: Ocular and systemic manifestations of PHACES (posterior fossa malformations, hemangiomas, arterial anomalies, cardiac defects and coarctation of the aorta, eye abnormalities, and Sternal abnormalities or ventral developmental defects) syndrome. J AAPOS. 9(2):169-73, 2005
Robertson RL et al: Head and neck vascular anomalies of childhood. Neuroimaging Clin N Am. 9(1):115-32, 1999
Mulliken JB et al: Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 69(3):412-22, 1982
Related Anatomy
Loading...
Related Differential Diagnoses
Loading...
References
Tables
Tables
KEY FACTS
Terminology
Imaging
Top Differential Diagnoses
Pathology
Clinical Issues
TERMINOLOGY
Abbreviations
Infantile hemangioma (IH)
Synonyms
Older, inappropriate terms: Hemangioma of infancy, capillary hemangioma
Widespread misuse of term hemangioma in literature
Benign vascular neoplasmof proliferating endothelial cells; most common soft tissue tumor of infancy
Not vascular malformation
2018 revised classification by International Society for Study of Vascular Anomalies (ISSVA) retains 2 main categories
Vascular tumors: True neoplasms with cellular proliferation; generally grow out of proportion to patient
Vascular malformation: Congenital errors of vessel development; generally grow commensurate with patient
IMAGING
General Features
Imaging Recommendations
DIFFERENTIAL DIAGNOSIS
PATHOLOGY
General Features
Microscopic Features
Immunohistochemical Features
CLINICAL ISSUES
Presentation
Demographics
Natural History & Prognosis
Treatment
DIAGNOSTIC CHECKLIST
Consider
Selected References
ISSVA 2018 Classification
Laken PA: Infantile hemangiomas: pathogenesis and review of propranolol use. Adv Neonatal Care. 16(2):135-42, 2016
Merrow AC et al: 2014 Revised classification of vascular lesions from the International Society for the Study of Vascular Anomalies: radiologic-pathologic update. Radiographics. 36(5):1494-516, 2016
Wassef M et al: Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics. 136(1):e203-14, 2015
Blei F et al: Current workup and therapy of infantile hemangiomas. Clin Dermatol. 32(4):459-70, 2014
Nasseri E et al: Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol. 70(1):75-9, 2014
Bingham MM et al: Propranolol reduces infantile hemangioma volume and vessel density. Otolaryngol Head Neck Surg. 147(2):338-44, 2012
Restrepo R et al: Hemangiomas revisited: the useful, the unusual and the new. Part 1: overview and clinical and imaging characteristics. Pediatr Radiol. 41(7):895-904, 2011
Restrepo R et al: Hemangiomas revisited: the useful, the unusual and the new. Part 2: endangering hemangiomas and treatment. Pediatr Radiol. 41(7):905-15, 2011
Holmes WJ et al: Propranolol as first-line treatment for infantile hemangiomas. Plast Reconstr Surg. 125(1):420-1, 2010
Maturo S et al: Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol. 74(3):323-5, 2010
Sinno H et al: Management of infantile parotid gland hemangiomas: a 40-year experience. Plast Reconstr Surg. 125(1):265-73, 2010
Storch CH et al: Propranolol for infantile haemangiomas - insights into the molecular mechanisms of action. Br J Dermatol. 163(2):269-74, 2010
Metry D et al: Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics. 124(5):1447-56, 2009
Judd CD et al: Intracranial infantile hemangiomas associated with PHACE syndrome. AJNR Am J Neuroradiol. 28(1):25-9, 2007
Drolet BA et al: Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics. 117(3):959-64, 2006
Rossi A et al: Agenesis of bilateral internal carotid arteries in the PHACE syndrome. AJNR Am J Neuroradiol. 27(8):1602, 2006
Kronenberg A et al: Ocular and systemic manifestations of PHACES (posterior fossa malformations, hemangiomas, arterial anomalies, cardiac defects and coarctation of the aorta, eye abnormalities, and Sternal abnormalities or ventral developmental defects) syndrome. J AAPOS. 9(2):169-73, 2005
Robertson RL et al: Head and neck vascular anomalies of childhood. Neuroimaging Clin N Am. 9(1):115-32, 1999
Mulliken JB et al: Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 69(3):412-22, 1982
STATdx includes over 200,000 searchable images, including x-ray, CT, MR, and ultrasound images. To access all images, please log in or subscribe.